MedTrace Logo

Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique

NCT04918082 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2026-03-31

No results posted yet for this study

Summary

Cancer and its treatments can be factors that alter the quality of life of patients. The induced alteration of the quality of life can influence compliance and impact survival. Considering the after-effects of the treatment, carrying out such a survey will provide for the first time precise information on the main determinants of the quality of life as well as on the care pathway of patients with invasive breast cancer in the Martinique region.

Conditions

  • Breast Neoplasms
  • Quality of Life
  • Survivorship

Interventions

OTHER

Quality of life questionnaires

Patients' quality of life will be assessed with self-reported items through both the EORTC-QLQ-C30 and EORTC-QLQ-BR23 modules.

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Clarisse JOACHIM-CONTARET · CHU Martinique

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2026-01-20
Completion
2027-03-31

Countries

  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918082 on ClinicalTrials.gov